News
Categories:
News
Genomill’s Bridge Capture™ Technology Featured in Elsevier News
Turku, Finland – 15.1.2026 – Genomill Health is pleased to announce that its […]
Blog
Genomill Health Eyes Clinical Adoption of Targeted NGS Technology
Turku, Finland – 18.8.2025 – We’re excited to be featured in GenomeWeb for our […]
Blog
Manu Tamminen on the Signaali Podcast
Turku, Finland – 11.8.2025 – Our CEO and co-founder Manu Tamminen joined the […]
News
Bridge Capture™ Enables Sensitive, Scalable Liquid Biopsy in Colorectal Cancer Pilot
Turku, Finland – 14.7.2025 — Genomill Health, a biotechnology company pioneering simplified targeted […]
News
Genomill Introduces Nicking Loop™: Pioneering Circular DNA Libraries for Next-Generation Sequencing
Turku, Finland – 12.5.2025 – Genomill is excited to announce the publication of […]
Announcements
Genomill Strengthens Leadership Team
Turku, Finland – 24.4.2025 – Genomill Health Oy, a pioneer in next-generation DNA technologies, is pleased to announce several key leadership appointments that mark a new chapter in the company’s growth.
Blog
Exploring the Future of DNA Sequencing: Genomill’s Visit to Illumina Cambridge
Cambridge, United Kingdom – 23.3.2025 – Dr. Manu Tamminen, Co-Founder of Genomill, recently […]
Blog
Genomill CEO Presents at PMWC 2025, Showcasing Advances in Circular DNA Technologies
Santa Clara, California – 7.2.2025 – Dr. Manu Tamminen, CEO and Co-Founder of […]
News
Bridge Capture™ by Genomill Represents a Major Leap Forward in Liquid Biopsy Diagnostics
Turku, Finland – 20.5.2024 – The new method will enable cost-efficient, rapid, and sensitive molecular precision diagnostics for cancer.
News
Genomill and Finland’s Cancer Research Flagship iCAN Partner To Improve Cancer Detection Using an Extensive Biobank Cohort
Helsinki, Finland – 13.06.2023 – Genomill and iCAN, the Finnish national cancer research flagship project, signed a partnership aiming to improve the detection of trace tumour DNA from thousands of biobank samples.